ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Shanghai Bio-Heart Biological Technology Co., Ltd. ?
1
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 0%
- Poor long term growth as Net Sales has grown by an annual rate of 186.07% and Operating profit at 22.67% over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -203.01
2
Flat results in Dec 24
- CASH AND EQV(HY) Lowest at HKD 215.38 MM
- DEBT-EQUITY RATIO (HY) Highest at -29.39 %
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 261.45%, its profits have risen by 52%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Miscellaneous)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Shanghai Bio-Heart Biological Technology Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Shanghai Bio-Heart Biological Technology Co., Ltd.
261.45%
1.74
107.32%
Hang Seng Hong Kong
27.36%
1.06
25.88%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
186.07%
EBIT Growth (5y)
22.67%
EBIT to Interest (avg)
-203.01
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.30
Sales to Capital Employed (avg)
0.03
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.77
EV to EBIT
-26.18
EV to EBITDA
-30.22
EV to Capital Employed
3.54
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-13.54%
ROE (Latest)
-14.40%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for Shanghai Bio-Heart Biological Technology Co., Ltd.
Net Profit
Higher at HKD -67.38 MM
than preceding 12 month period ended Dec 2024MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (HKD MM)
Raw Material Cost
Fallen by 0% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Shanghai Bio-Heart Biological Technology Co., Ltd.
Cash and Eqv
Lowest at HKD 215.38 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Debt-Equity Ratio
Highest at -29.39 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
